跳至主要内容
临床试验/NCT02984176
NCT02984176已完成4 期

Simethicone and Gynecological Laparoscopies: Does it Improve Operative Field and Postoperative Pain?

Woman's Health University Hospital, Egypt0 个研究点目标入组 100 人开始时间: 2014年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
100
主要终点
five-point scale

研究概览

简要总结

Simethicone is an oral anti-foaming agent that reduces bloating, abdominal discomfort, and abdominal pain by promoting the clearance of excessive gas along the gastrointestinal tract.

The investigators objective is to evaluate the efficacy and safety of preoperative oral simethicone for bowel preparation in gynecological laparoscopies.

详细描述

Introduction

Simethicone is an oral antifoaming agent that reduces bloating, abdominal discomfort, and abdominal pain by promoting the clearance of excessive gas along the gastrointestinal tract.

Objective

to evaluate the efficacy and safety of preoperative oral simethicone for bowel preparation in gynecological laparoscopies.

Methods: 100 infertile women will be scheduled for laparoscopy, patients randomized to receive either Simethicone (Group I) or placebo tablets (Group II). The primary outcome measure will be the overall exposure of the surgical field and pain scoring. Assessment of the overall exposure of the surgical field was done using a five-point scale (poor, sufficient, medium, good, and excellent). Visual analog score (VAS) will be used for assessment of postoperative pain and verbal analog scoring was used for assessment of patient satisfaction.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
20 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Infertile patients
  • aged 20 - 40 years old
  • scheduled for laparoscopy

排除标准

  • Women were excluded from the study if patients had one or more of the following:
  • scar of previous operation, uterine mass, severe endometriosis, suspicion of malignancy, history of allergic reaction to study drugs, psychiatric disorders and patient refusal

研究组 & 干预措施

Simethicone

Active Comparator

Arm 1 or Group I or Simethicone 40mg. 3 tablets (one tablet after each meal) and to fast overnight the day before the operation.

干预措施: Simethicone Tab 40 mg (Drug)

placebo

Placebo Comparator

Arm 2 or group 2 or placebo group. 3 tablets (one tablet after each meal) and to fast overnight the day before the operation.

干预措施: Placebo Tablets (Drug)

结局指标

主要结局

five-point scale

时间窗: 1 hour

次要结局

  • Patient satisfaction(24 hours)
  • VAS(24 hours)
  • The degree of bowel preparation(1 hour)

研究者

发起方
Woman's Health University Hospital, Egypt
申办方类型
Other
责任方
Principal Investigator
主要研究者

Kamal Mohamed Zahran

Assistant professor of Obstetrics & Gynecology, Faculty of Medicine, Consultant and vice director, Women's Health Hospital, Assiut University, Egypt

Woman's Health University Hospital, Egypt

相似试验